Trials / Completed
CompletedNCT02244710
EndoTic - Endothelium and Ticagrelor
EndoTic - Endothelium and Ticagrelor: Pharmacological Effects Beyond Antiplatelet Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 109 (actual)
- Sponsor
- Fundación Investigación Sanitaria en León · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Randomized clinical trial to assess the influence of treatment with ticagrelor or clopidogrel in the number of CECs (Circulating Endothelial Cells) and EPCs (Endothelial Progenitor Cells) in patients with ACS (Acute Coronary Syndrome), from baseline levels to chronic levels (1 month).
Detailed description
ACS Patients in both treatment groups will be assessed: Baseline, 48h and 1 month cell counts will be done for CECs and EPCs Platelet Function at 48h and 1month Adverse Events, ECG and blood testing result will be also collected
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ticagrelor vs Clopidogrel |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2014-09-19
- Last updated
- 2016-11-23
Locations
3 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02244710. Inclusion in this directory is not an endorsement.